Headquartered in Mumbai India, GenPharma is with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment.
Everyday, they strive to discover new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of functioning.
Alembic Limited, with an established presence in the Indian pharma industry has a proud, historical track record going back one hundred years. With a turnover in excess of Rs1000 crores today, Alembic Limited is one of India’s leading integrated pharmaceutical companies.
The National Centre for Cell Science (NCCS) took birth as National Tissue Culture Facility in March 11, 1986 with a mandate of basic research, teaching & training, and as a national repository for cell lines/hybridomas etc. The centre is located in the midst of academically enriched environment of University of Pune campus, Pune.
Alembic Limited, with an established presence in the Indian pharma industry has a proud, historical track record going back one hundred years. With a turnover in excess of Rs1000 crores today, Alembic Limited is one of India’s leading integrated pharmaceutical companies.
This time people performed well. looks like approved than previous tests. Passing marks was 40 % and so many of the candidates reach there to pass. Let me remind you there was no negative marks system otherwise it can affect your result. But anyways overall it was nice performance.
Nestle India is a subsidiary of Nestle S.A. of Switzerland. With seven factories and a large number of co-packers, Nestle India is a vibrant Company that provides consumers in India with products of global standards and is committed to long-term sustainable growth and shareholder satisfaction.
Based in Mumbai ICPA operates throughout India, Nepal, Srilanka, Bangladesh, Yemen, Myanmar and Malaysia and is working at an accelerated pace to start operations in many other countries in the near future.
That was real traffic of candidates on GPAT-TUTOR Platform for OCF 2011's test-2. The no. of candidates participating in OCF competition is increased for TEST-2. The test was much easier than test -1 and passing percentage was 50 % ... But Let me tell you very few of you cross that margin. But don’t worry as in GPAT if you would score atleast 35-40 %, you can qualify the pharma giant entrance.